Medical Research News

RSS

Study: Salivary gland ectasia reflects hyperinflammatory response to COVID-19

The clinical picture of COVID-19 in various target organs has been extensively studied and described, but relatively little is known about the characteristics of oral cavity involvement.

4 Mar 2021

Evolutionary forces account for gender imbalance in the occurrence of autism, other health conditions

Evolutionary forces drive a glaring gender imbalance in the occurrence of many health conditions, including autism, a team of genetics researchers has concluded.

4 Mar 2021

Frequent moisturization of infants can lead to food allergies

Analysis of data from a trial of more than 1,300 infants has found that increased application of moisturizers at three months of age was associated with a higher likelihood of developing allergies in infancy.

4 Mar 2021

Study reports persistent SARS-CoV-2 with increasing viral variants in pediatric patients

New research, published on medRxiv preprint server, has reported the effect of prolonged SARS-CoV-2 infection in immunocompromised children and young adults.

4 Mar 2021

Study reveals the devastating economic impact of eating disorders in the U.S.

The impact of eating disorders in the United States was nearly $400 billion in 2018-19 when considering both economic costs and reduced wellbeing, according to a study published in the International Journal of Eating Disorders.

4 Mar 2021

Researchers identify the trigger of key cellular change in amyotrophic lateral sclerosis

Scientists at the Francis Crick Institute and UCL have identified the trigger of a key cellular change in amyotrophic lateral sclerosis (ALS), a type of motor neurons disease.

4 Mar 2021

SARS-CoV-2 variants do not substantially affect CD4+ and CD8+ T cell responses, study shows

Researchers from California in the United States have conducted a study showing that important adaptive immune responses to infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are not affected by four recently emerged variants of the virus.

3 Mar 2021

Wikipedia maintained high-quality COVID-19 coverage during first pandemic wave

Researchers in Israel have demonstrated that Wikipedia's coverage of the coronavirus disease 2019 (COVID-19) pandemic continued to be based on respected media and academic sources, despite a surge in coverage as the pandemic grew during the first wave.

3 Mar 2021

Study shows lower antibody cross-reactivity after infection with the B.1.1.7 SARS-CoV-2 variant

In a recent research paper currently available on the bioRxiv* preprint server, a diverse group of researchers has examined the immunogenicity of antibodies against the variant B.1.1.7 of the severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) initially found in the United Kingdom – and revealed diminished recognition and neutralization of either parental strains or the South African variant.

3 Mar 2021

COVID risk to households and teachers from in person schooling

When researchers analyzed the responses of the COVID-19 Symptom Survey in the United States, they found an increased risk of COVID-19 for household members when children had in-person schooling.

3 Mar 2021

Results from phase 2 trial of Novavax recombinant nanoparticle SARS-CoV-2 vaccine

Novavax, Inc., the American vaccine development company, has been developing a recombinant protein nanoparticle COVID-19 vaccine currently termed NVX-CoV2373. The full-length spike protein of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is created in a baculovirus vector, which is then inserted into a lipid nanoparticle around 50 nm in diameter.

3 Mar 2021

Genetic variation associated with COVID-19 outcome

Host genetics play a role in disease progression and prognosis. A paper recently uploaded to the preprint server medRxiv by Dubé et al. (1st March 2021) identifies several alleles associated with the gene natriuretic peptide receptor C (NPR3) that may impact disease severity.

3 Mar 2021

Newly identified biomarker could predict response to immune checkpoint inhibitors

A team of Roswell Park Comprehensive Cancer Center researchers has identified a new biomarker that could predict response to immune checkpoint inhibitors (ICI) shortly after patients with non-small cell lung cancer (NSCLC) initiate therapy.

3 Mar 2021

Improving nurse staffing in New York hospitals could reduce deaths, save money

According to a new study published in Medical Care, improving hospital nurse staffing as proposed in pending legislation in New York state would likely save lives.

3 Mar 2021

Researchers explore mutational signatures associated with exposure to microplastic pollutants

According to the World Health Organization, plastic products and their chemical derivatives present in the environment present public health concerns on a global scale and more exploration on the potential impact to human health is needed.

3 Mar 2021

Study reveals how racial discrimination in home-renting affects environmental inequality

Economists and urban planners generally agree that local pollution sources disproportionally impact racial minorities in the U.S. The reasons for this are largely unclear, but a University of Illinois study provides new insights into the issue.

3 Mar 2021

Cigarette smoke toxicity impacts protective biofilm in the lungs, study finds

Ben-Gurion University of the Negev Researchers (BGU) have found for the first time that cigarette smoke toxicity impacts the protective biofilm in the lungs, particularly concerning when paired with COVID-19 respiratory issues.

3 Mar 2021

People diagnosed with alpha-1 antitrypsin deficiency more likely to stop smoking, study shows

New research shows that people diagnosed with a genetic condition, called alpha-1 antitrypsin deficiency (AATD), are far more likely to stop smoking and therefore prevent the development of lung disease.

3 Mar 2021

Pfizer SARS-CoV-2 vaccine effective from day 11 post 1st vaccination

New research from a team of scientists in Australia finds that the second ‘booster’ dose of the Pfizer-BioNTech vaccine did not increase vaccine efficacy against severe acute respiratory syndrome (SARS-CoV-2), the causative agent of coronavirus disease 2019 (COVID-19). The results suggest one dose of the vaccine was sufficient in providing a robust immune response 11 days after inoculation.

3 Mar 2021

Using two different viruses to tackle tumors

An international research group led by the University of Basel has developed a promising strategy for therapeutic cancer vaccines.

3 Mar 2021

Medical Research News

Study: Salivary gland ectasia reflects hyperinflammatory response to COVID-19

Evolutionary forces account for gender imbalance in the occurrence of autism, other health conditions

Frequent moisturization of infants can lead to food allergies

Study reports persistent SARS-CoV-2 with increasing viral variants in pediatric patients

Study reveals the devastating economic impact of eating disorders in the U.S.

Researchers identify the trigger of key cellular change in amyotrophic lateral sclerosis

SARS-CoV-2 variants do not substantially affect CD4+ and CD8+ T cell responses, study shows

Wikipedia maintained high-quality COVID-19 coverage during first pandemic wave

Study shows lower antibody cross-reactivity after infection with the B.1.1.7 SARS-CoV-2 variant

COVID risk to households and teachers from in person schooling

Results from phase 2 trial of Novavax recombinant nanoparticle SARS-CoV-2 vaccine

Genetic variation associated with COVID-19 outcome

Newly identified biomarker could predict response to immune checkpoint inhibitors

Improving nurse staffing in New York hospitals could reduce deaths, save money

Researchers explore mutational signatures associated with exposure to microplastic pollutants

Study reveals how racial discrimination in home-renting affects environmental inequality

Cigarette smoke toxicity impacts protective biofilm in the lungs, study finds

People diagnosed with alpha-1 antitrypsin deficiency more likely to stop smoking, study shows

Pfizer SARS-CoV-2 vaccine effective from day 11 post 1st vaccination

Using two different viruses to tackle tumors

Advancing Drug Safety Assessment With AI, Predictive Modeling, and Human-Relevant Data

AI-powered analytics and experimental validation

Membrane proteins in focus: Turning high-risk targets into routine workflows

Latest News